Company Monitoring Page for Amylin

latest headlines for company on cafepharma

3 PDUFA Dates That Will Kick Off 2014
Motley Fool
Tue, 08/27/13 - 05:34 pm
Tags:
FDA, diabetes, Forixga, Bristol-Myers Squibb, AstraZeneca, Biomarin, Vimizim, Amylin, metreleptin
Bristol-Myers to close Amylin's headquarters in San Diego and cut about 300 jobs
Yahoo/AP
Thu, 04/4/13 - 01:49 pm
Tags:
Amylin, Bristol-Myers Squibb, layoffs
Takeda and Amylin terminate obesity compound co-development agreement
equities.com
Sat, 12/29/12 - 10:38 am
Tags:
Takeda, Amylin, obesity, weight loss
Takeda writes off its $1B obesity deal with Amylin
Fierce Biotech
Fri, 12/28/12 - 11:59 am
Tags:
Amylin, Takeda
Novo Nordisk says new data show Victoza advantage
Reuters
Tue, 11/27/12 - 10:36 am
Tags:
diabetes, Novo Nordisk, Victoza, Merck, Amylin
3 Diabetes Phase 3 Wins
Motley Fool
Tue, 10/23/12 - 04:19 pm
Tags:
Merck, Sanofi, Eli Lilly, diabetes, AstraZeneca, Bristol-Myers Squibb, dulaglutide, Amylin
Lilly Backs Broad Diabetes Range to Challenge Rivals
Bloomberg
Mon, 10/8/12 - 12:53 pm
Tags:
Eli Lilly, diabetes, Boehringer Ingelheim, Amylin, LY2605541, GLP-1 agonist, SGLT2 inhibitor
Novo Says It’s Likely to Benefit From Bristol-Amylin Tie-Up
Bloomberg
Fri, 10/5/12 - 11:25 am
Tags:
Bristol-Myers Squibb, Novo Nordisk, Amylin, diabetes
Bristol-Myers Squibb - Between Patent Deadlines And Revenue Shifts
Seeking Alpha
Wed, 10/3/12 - 10:50 am
Tags:
patents, Bristol-Myers Squibb, Amylin, AstraZeneca, Novo Nordisk, Eli Lilly, Merck
3 Things to Watch in the Pharmaceutical Sector Right Now
Motley Fool
Tue, 09/4/12 - 11:05 am
Tags:
Amylin, Bristol-Myers Squibb, Arena Pharmaceuticals, Pfizer
Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term
Seeking Alpha
Mon, 08/27/12 - 05:27 pm
Tags:
Amylin, M&A, Bristol-Myers Squibb, Merck, Eli Lilly, AstraZeneca, diabetes
AstraZeneca buys equal say over Amylin drugs
Reuters
Thu, 08/9/12 - 10:56 am
Tags:
Amylin, AstraZeneca, diabetes, Bristol-Myers Squibb
Bristol-Myers completes acquisition of Amylin
Yahoo/Fly on the Wall
Thu, 08/9/12 - 10:43 am
Tags:
M&A, Amylin, Bristol-Myers Squibb
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
Tags:
drug approvals, earnings, Amylin, InterMune, Human Genome Sciences, GSK, Bristol-Myers Squibb, Questcor, BiogenIdec, Alexion, Regeneron, Eli Lilly, Amarin, Horizon Pharma, Celgene, Amgen, Gilead, Alkermes, United Therapeutics, Roche, Sanofi, Merck, AstraZeneca, Salix, Progenics Pharmaceuticals
Eli Lilly, Verastem and the Defenders of Shareholder Value
TheStreet.com
Mon, 07/16/12 - 12:16 pm
Tags:
Eli Lilly, Verastem, Celgene, QLT, Amylin
2 Highly Attractive Pharmaceutical Companies Set To Soar
Seeking Alpha
Mon, 07/16/12 - 12:14 pm
Tags:
Vivus, Pfizer, Arena Pharmaceuticals, Amylin, Abbott Laboratories
Hedge Funds Are Buying These 10 High-Growth Biotech Stocks
Seeking Alpha
Sun, 07/15/12 - 11:30 am
Tags:
Xoma, Jazz Pharmaceuticals, Pacific Biosciences, Amylin, Corcept Therapeutics, Santarus, Affymetrix, Ariad Pharmaceuticals, Amyris, Sequenom
Profit From GlaxoSmithKline's Mistake
Seeking Alpha
Fri, 07/13/12 - 01:23 pm
Tags:
GSK, Amylin, AstraZeneca, Merck, Novartis, Pfizer
Bristol-Myers starts tender offer for Amylin
Reuters
Tue, 07/10/12 - 11:14 am
Tags:
tender offer, M&A, Amylin, Bristol-Myers Squibb
A Possible Bidding War For Human Genome Sciences, But Celgene Is The Real Gem
Seeking Alpha
Mon, 07/9/12 - 10:12 am
Tags:
M&A, Human Genome Sciences, Celgene, Amylin, GSK, Novo Nordisk

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.